Baker Bros. Advisors’s Acrivon Therapeutics ACRV Stock Holding History

Baker Bros. Advisors’s Portfolio ACRV Stock Details ACRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$27.1K	Hold
2025 Q1	$46.3K	Sell
2024 Q4	$318K	Hold
2024 Q3	$370K	Hold
2024 Q2	$307K	Hold
2024 Q1	$378K	Buy